Alector to Participate in Upcoming Healthcare Conferences
09 May 2024 - 9:00PM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology
company pioneering immuno-neurology, today announced that
management will participate in the following upcoming investor
conferences:
- Bank of America Securities Health
Care Conference (Las Vegas, Nevada)
- Tuesday, May 14, 2024, at 8:55 a.m.
PT, corporate presentation
- H.C. Wainwright 2nd Annual
BioConnect Investor Conference (New York, New York)
- Monday, May 20, 2024, at 11:00 a.m.
ET, fireside chat
A webcast of each conference presentation will be available on
the “Events & Presentations” page within the Investors section
of the Alector website at http://investors.alector.com. Replays of
the webcasts will be available on the Alector website for 90 days
following the presentation dates.
About AlectorAlector is a clinical-stage
biotechnology company pioneering immuno-neurology, a novel
therapeutic approach for the treatment of neurodegenerative
diseases. Immuno-neurology targets immune dysfunction as a root
cause of multiple pathologies that are drivers of degenerative
brain disorders. Alector has discovered and is developing a broad
portfolio of innate immune system programs, designed to
functionally repair genetic mutations that cause dysfunction of the
brain’s immune system and enable rejuvenated immune cells to
counteract emerging brain pathologies. Alector’s immuno-neurology
product candidates are supported by biomarkers and seek to treat
indications, including Alzheimer’s disease and genetically defined
frontotemporal dementia patient populations. Alector is
headquartered in South San Francisco, California.
Alector Contacts: AlectorKatie
Hogan202-549-0557katie.hogan@alector.com
1AB (media) Dan Budwick 973-271-6085 dan@1abmedia.com
Argot Partners (investors)Laura
Perry212.600.1902alector@argotpartners.com
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Jul 2023 to Jul 2024